Imlygic Drug Interactions
Currently displaying a list of 302 drugs known to interact with Imlygic (talimogene laherparepvec).
- 282 major drug interactions
- 20 moderate drug interactions
Medications known to interact with Imlygic
Note: Showing generic names only.
- abatacept
- abemaciclib
- abrocitinib
- acalabrutinib
- acyclovir
- acyclovir topical
- adalimumab
- afamitresgene autoleucel
- aldesleukin
- alefacept
- alemtuzumab
- allogeneic processed thymus tissue
- altretamine
- anakinra
- anifrolumab
- anti-thymocyte globulin (rabbit)
- asciminib
- asparaginase escherichia coli
- atezolizumab
- atidarsagene autotemcel
- avacopan
- avapritinib
- avelumab
- axicabtagene ciloleucel
- azacitidine
- azathioprine
- baricitinib
- basiliximab
- belantamab mafodotin
- belatacept
- belimumab
- belinostat
- bendamustine
- betamethasone
- bexarotene
- bimekizumab
- bleomycin
- blinatumomab
- bortezomib
- bosutinib
- brentuximab
- brexucabtagene autoleucel
- brigatinib
- brodalumab
- budesonide
- busulfan
- cabazitaxel
- canakinumab
- capecitabine
- carboplatin
- carfilzomib
- carmustine
- cemiplimab
- certolizumab
- chlorambucil
- chloramphenicol
- ciltacabtagene autoleucel
- cisplatin
- cladribine
- clofarabine
- cobimetinib
- copanlisib
- corticotropin
- cortisone
- cosibelimab
- crizotinib
- crovalimab
- cyclophosphamide
- cyclosporine
- cytarabine
- dacarbazine
- daclizumab
- dactinomycin
- danicopan
- daratumumab
- dasatinib
- daunorubicin
- daunorubicin liposomal
- decitabine
- deflazacort
- denileukin diftitox
- deucravacitinib
- dexamethasone
- dexrazoxane
- dimethyl fumarate
- dinutuximab
- diroximel fumarate
- docetaxel
- dostarlimab
- doxorubicin
- doxorubicin liposomal
- dupilumab
- durvalumab
- duvelisib
- eculizumab
- efalizumab
- efgartigimod alfa
- eflornithine
- elivaldogene autotemcel
- elotuzumab
- elranatamab
- emapalumab
- enfortumab vedotin
- epcoritamab
- epirubicin
- eribulin
- etanercept
- etoposide
- etrasimod
- everolimus
- exagamglogene autotemcel
- fam-trastuzumab deruxtecan
- famciclovir
- fexinidazole
- fingolimod
- floxuridine
- fludarabine
- fludrocortisone
- fluorouracil
- fruquintinib
- ibritumomab
- ibrutinib
- idarubicin
- idecabtagene vicleucel
- idelalisib
- ifosfamide
- imatinib
- imetelstat
- inavolisib
- inebilizumab
- infliximab
- inotuzumab ozogamicin
- iobenguane I 131
- iodine i 131 tositumomab
- ipilimumab
- iptacopan
- irinotecan
- irinotecan liposomal
- isatuximab
- ixabepilone
- ixazomib
- ixekizumab
- lebrikizumab
- leflunomide
- lenalidomide
- levamisole
- lifileucel
- lisocabtagene maraleucel
- lomustine
- loncastuximab tesirine
- lovotibeglogene autotemcel
- lurbinectedin
- lutetium lu 177 dotatate
- lutetium lu 177 vipivotide tetraxetan
- lymphocyte immune globulin, anti-thy (equine)
- mechlorethamine
- melphalan
- melphalan flufenamide
- mercaptopurine
- methotrexate
- methylprednisolone
- midostaurin
- mirikizumab
- mitomycin
- mitoxantrone
- mogamulizumab
- momelotinib
- monomethyl fumarate
- muromonab-cd3
- mycophenolate mofetil
- mycophenolic acid
- obecabtagene autoleucel
- obinutuzumab
- ocrelizumab
- ofatumumab
- olaparib
- olaratumab
- omacetaxine
- osimertinib
- oxaliplatin
- ozanimod
- paclitaxel
- paclitaxel protein-bound
- pacritinib
- palbociclib
- panobinostat
- pazopanib
- pegaspargase
- pegcetacoplan
- pembrolizumab
- pemetrexed
- penciclovir topical
- penpulimab
- pentostatin
- pirtobrutinib
- plicamycin
- polatuzumab vedotin
- pomalidomide
- ponatinib
- ponesimod
- pozelimab
- pralatrexate
- prednisolone
- prednisone
- procarbazine
- ravulizumab
- retifanlimab
- revumenib
- ribociclib
- rilonacept
- risankizumab
- ritlecitinib
- rituximab
- romidepsin
- ropeginterferon alfa-2b
- rozanolixizumab
- rucaparib
- ruxolitinib
- ruxolitinib topical
- sacituzumab govitecan
- sarilumab
- satralizumab
- secukinumab
- selinexor
- siltuximab
- siponimod
- sirolimus
- sirolimus protein-bound
- sirolimus topical
- spesolimab
- streptozocin
- sutimlimab
- tacrolimus
- tafasitamab
- talazoparib
- talquetamab
- tarlatamab
- tazemetostat
- teclistamab
- temozolomide
- temsirolimus
- teniposide
- teplizumab
- teriflunomide
- tezepelumab
- thalidomide
- thioguanine
- thiotepa
- tildrakizumab
- tisagenlecleucel
- tislelizumab
- tisotumab vedotin
- tocilizumab
- tofacitinib
- topotecan
- toripalimab
- tositumomab
- trabectedin
- tralokinumab
- trastuzumab
- tremelimumab
- treosulfan
- triamcinolone
- triamcinolone ophthalmic
- trimetrexate
- valacyclovir
- vamorolone
- vedolizumab
- venetoclax
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- voclosporin
Imlygic disease interactions
There are 4 disease interactions with Imlygic (talimogene laherparepvec) which include:
More about Imlygic (talimogene laherparepvec)
- Imlygic consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer, such as melanoma, non-small cell lung cancer ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Tecentriq
Tecentriq (atezolizumab) is a monoclonal antibody used to treat non-small cell lung cancer, small ...
Yervoy
Yervoy (ipilimumab) is a cancer treatment used for lung cancer, melanoma, renal cell carcinoma ...
Tafinlar
Tafinlar is a prescription medicine used to treat BRAF mutated melanoma, non-small cell lung ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
Opdualag
Opdualag (nivolumab and relatlimab-rmbw) is used for the treatment of unresectable or metastatic ...
Interferon alfa-2b
Interferon alfa-2b is used for angioblastoma, condylomata acuminata, conjunctival mucosa-associated ...
Dacarbazine
Dacarbazine is used for hodgkin's lymphoma, melanoma, melanoma, metastatic
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.